EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $465,190 | -22.7% | 45,922 | -40.5% | 0.34% | -27.5% |
| Q3 2023 | $602,066 | +18.3% | 77,188 | +24.8% | 0.46% | +38.3% |
| Q2 2023 | $508,984 | +19.7% | 61,845 | +5.4% | 0.33% | +12.1% |
| Q1 2023 | $425,365 | -19.6% | 58,671 | -1.6% | 0.30% | -32.1% |
| Q4 2022 | $529,000 | -23.9% | 59,655 | +5.0% | 0.44% | -25.5% |
| Q3 2022 | $695,000 | -82.7% | 56,798 | -83.3% | 0.59% | -36.3% |
| Q2 2022 | $4,022,000 | +336.7% | 339,944 | +602.2% | 0.92% | +48.8% |
| Q1 2022 | $921,000 | -4.2% | 48,413 | +33.7% | 0.62% | -4.3% |
| Q4 2021 | $961,000 | -26.1% | 36,214 | +14.4% | 0.65% | -27.7% |
| Q3 2021 | $1,301,000 | -25.7% | 31,662 | +2.4% | 0.90% | -24.7% |
| Q2 2021 | $1,752,000 | +295.5% | 30,925 | +193.0% | 1.19% | +172.4% |
| Q1 2021 | $443,000 | +4.7% | 10,553 | +74.8% | 0.44% | -14.3% |
| Q4 2020 | $423,000 | – | 6,036 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |